Te Ahumairangi Investment Management LTD Bristol Myers Squibb CO Transaction History

Te Ahumairangi Investment Management LTD

$473 Million
Q1 2025

A detailed history of Te Ahumairangi Investment Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Te Ahumairangi Investment Management LTD holds 58,497 shares of BMY stock, worth $2.74 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

58,497

Previous 73,144 20.02%

Holding current value

$2.74 Million

Previous $4.14 Million 13.75%

% of portfolio

0.76%

Previous 0.86%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$53.9 - $63.11 $789,473 - $924,372	-14,647 Reduced 20.02%	58,497 $3.57 Million
Q4 2024 Feb 12, 2025	SELL	$51.92 - $59.94 $1.86 Million - $2.15 Million	-35,803 Reduced 32.86%	73,144 $4.14 Million
Q3 2024 Nov 21, 2024	SELL	$39.66 - $51.75 $1.47 Million - $1.92 Million	-37,110 Reduced 25.41%	108,947 $5.61 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $156,975 - $206,661	-3,900 Reduced 2.6%	146,057 $6.07 Million
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $203,915 - $231,200	4,250 Added 2.92%	149,957 $8.13 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $760,408 - $907,377	-15,685 Reduced 9.72%	145,707 $7.48 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $85,098 - $95,153	1,470 Added 0.92%	161,392 $9.37 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.22 Million - $1.35 Million	19,145 Added 13.6%	159,922 $10.2 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $1.04 Million - $1.18 Million	15,865 Added 12.7%	140,777 $9.76 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $1.38 Million - $1.63 Million	20,145 Added 19.23%	124,912 $8.99 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $284 - $168,279	2,190 Added 2.13%	104,767 $7.45 Million
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $50,834 - $55,986	-700 Reduced 0.68%	102,577 $7.9 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $36,888 - $44,232	600 Added 0.58%	103,277 $7.54 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $182,342 - $212,568	-3,400 Reduced 3.21%	102,677 $6.4 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $414,190 - $485,170	7,000 Added 7.07%	106,077 $6.28 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $290,977 - $316,874	4,700 Added 4.98%	99,077 $6.62 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $741,750 - $834,249	12,500 Added 15.27%	94,377 $5.96 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $1.31 Million - $1.49 Million	22,700 Added 38.36%	81,877 $5.08 Million
Q3 2020 Nov 17, 2020	BUY	$57.43 - $63.64 $3.4 Million - $3.77 Million	59,177 New	59,177 $3.57 Million

Others Institutions Holding BMY

# of Institutions

2,810

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.8B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Te Ahumairangi Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Te Ahumairangi Investment Management LTD with notifications on news.

Account

Te Ahumairangi Investment Management LTD Bristol Myers Squibb CO Transaction History